OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Complicated biomolecules call for alternative drug delivery strategies.
Data management strategy is important for generating successful analytical studies.
Early control architecture decisions impact a facility’s long-term capabilities.
Bioassay studies for biosimilars enables regulatory pathway.
Large-scale SUBs prove successful as limits are tested.
AstraZeneca’s AZD7442 Clinical Trial Meets Primary Endpoint
October 18, 2021
Evonik’s LIPEX Flow extruder is a new version of its high-pressure equipment for manufacturing liposomal drug products.
October 15, 2021
The council voted 19–0 to recommend that FDA authorize booster doses of the Moderna COVID-19 vaccine for certain populations.
In this collaboration, Takeda will utilize Poseida's biodegradable DNA and RNA nanoparticle delivery technology and other proprietary genetic engineering platforms for the research and development of gene therapies.
MilliporeSigma announced the opening of its second Carlsbad, California-based facility, which doubles production capacity to support commercial and industrial manufacturing of viral vectors.
After months of deliberation, Biden plans to appoint cardiologist Robert Califf as FDA commissioner.
October 14, 2021
Aceto will acquire A&C Bio Buffer, including the company’s custom buffer and chemical blend portfolio.
The collaboration between Intellia and SparingVision will work to develop genomic medicines for ocular diseases.
This acquisition grants Bionano access to BioDiscovery’s clinical software solution for variant analysis.
Pharmalex has launched the Biopharma Excellence brand, a new service line that combines the expertise of PharmaLex, ERA Consulting, and Biopharma Excellence.
SGS is investing in a new E&L lab in Navi Mumbai, India, that will provide testing services.
AION Labs will be a first-of-its-kind AI/pharma and computational biology innovation lab aimed at spearheading the adoption of AI technologies and computational science.
The BioPharm International and Pharmaceutical Technology editors host industry experts, highlighting trends and new technologies.